CDN-CORE
WGS
Codon Core WGS
The complete 30× whole genome, the foundation every other panel reads against, re-analyzed as knowledge grows.
3.2BBase pairs
72hTurnaround
Now sequencing · CLIA-certified · CAP-accredited
Codon pairs 30x whole-genome sequencing with a precision-therapeutics engine, turning three billion base pairs into a clinical plan for longer, healthier lives.
Across research and clinical programs since 2019.
Annotated against ClinVar, gnomAD and internal cohorts.
From preclinical discovery through Phase III.
Ordering providers active twelve months on.
A single blood or saliva draw moves through extraction, library prep, sequencing and interpretation without ever leaving our accredited lab, no third-party handoffs, no black boxes.
Automated DNA extraction and PCR-free library construction on the Codon liquid-handling line, standardized for reproducibility.
Hybrid Illumina and Oxford Nanopore chemistry resolves structural variants and phasing that short reads alone miss.
Alignment, variant calling and ACMG classification in a validated bioinformatics pipeline with per-run QC gates.
Board-certified geneticists sign out every report; genetic counseling is included with each clinical result.
The complete 30× whole genome, the foundation every other panel reads against, re-analyzed as knowledge grows.
Hereditary cancer risk across 427 genes including BRCA1/2, Lynch and TP53, with actionable surveillance guidance.
Inherited cardiomyopathy, arrhythmia and aortopathy genes, phased to distinguish variants in cis from trans.
Trio analysis for undiagnosed neurodevelopmental disease, combining WGS with repeat-expansion detection.
CPIC-guided pharmacogenomics across 23 star-allele genes, mapping drug response before the first prescription.
Polygenic scores and epigenetic-age readouts for metabolic, cardiovascular and cognitive trajectories over time.
Programs advancing genetically defined medicines, each seeded by a signal first seen in our sequencing cohort.
Codon Labs holds CLIA certification and CAP accreditation; every clinical assay is validated and monitored under a documented quality system.
Genomic and health data are encrypted in transit and at rest under HIPAA safeguards, with role-based access and full audit trails.
Research use is opt-in and revocable. Participants control secondary use and can withdraw and request deletion at any time.
Reports and data exchange follow GA4GH and HL7 FHIR genomics standards so results move cleanly into the EHR.
Partner with Codon as a clinician, health system or research program. We will walk you through onboarding, ordering and reporting.